Evidence map›Paper›PMID 26969252›Full record

ArticleMetabolic engineering2016

Employing bacterial microcompartment technology to engineer a shell-free enzyme-aggregate for enhanced 1,2-propanediol production in Escherichia coli.

Matthew J Lee, Ian R Brown, Rokas Juodeikis, Stefanie Frank, Martin J Warren

Open access · hybridAbstract read
In one paragraph

Article in Metabolic engineering, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Application of artificial scaffold systems in microbial metabolic engineering.Frontiers in bioengineering and biotechnology · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Advances in the World of Bacterial Microcompartments.Trends in biochemical sciences · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew J LeeSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK.
Ian R BrownSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK.
Rokas JuodeikisSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK.
Stefanie FrankSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK. Electronic address: S.Frank@kent.ac.uk.
Martin J WarrenSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK. Electronic address: m.j.warren@kent.ac.uk.
University of Kent · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M002969/1
6 · The paper itself

Abstract

Bacterial microcompartments (BMCs) enhance the breakdown of metabolites such as 1,2-propanediol (1,2-PD) to propionic acid. The encapsulation of proteins within the BMC is mediated by the presence of targeting sequences. In an attempt to redesign the Pdu BMC into a 1,2-PD synthesising factory using glycerol as the starting material we added N-terminal targeting peptides to glycerol dehydrogenase, dihydroxyacetone kinase, methylglyoxal synthase and 1,2-propanediol oxidoreductase to allow their inclusion into an empty BMC. 1,2-PD producing strains containing the fused enzymes exhibit a 245% increase in product formation in comparison to un-tagged enzymes, irrespective of the presence of BMCs. Tagging of enzymes with targeting peptides results in the formation of dense protein aggregates within the cell that are shown by immuno-labelling to contain the vast majority of tagged proteins. It can therefore be concluded that these protein inclusions are metabolically active and facilitate the significant increase in product formation.

Indexed as

Artificial CellsBacterial ProteinsBiosynthetic PathwaysCell CompartmentationEscherichia coliGenetic EnhancementMetabolic EngineeringMetabolic Networks and PathwaysMultienzyme ComplexesPropylene GlycolProteinsRecombinant Fusion ProteinsBacterial ProteinsMultienzyme ComplexesPropylene GlycolProteinsRecombinant Fusion ProteinsBiotechnologyCompartmentalisationMetabolic engineeringProtein aggregationSynthetic biology

Identifiers

PMID26969252
PMCPMC4909751
OpenAlexW2295738977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.